Other Updated 2023-06-21

Certain bottles of JAMP Venlafaxine XR 37.5 mg capsules recalled due to mislabelling that could lead to overdose

See all recalls from Certain →
Share: Facebook X / Twitter WhatsApp

Recalled Product

JAMP Venlafaxine XR 37.5 mg (lot PTC5140A) sold to pharmacies in bottles of 100 capsules for dispensing.


✅ What Should You Do?

  1. ⚠️ Stop using this product until you have checked the recall details below.
  2. Check the capsules in your pharmacy bottle of JAMP Venlafaxine XR 37.5 mg capsules to make sure it contains 37.5 mg capsules (grey / pink in colour) and not 150 mg capsules (caramel in colour).
  3. 💰 Check if you are eligible for a refund or free replacement from the retailer or manufacturer.
  4. 📋 Report a product safety incident to Health Canada
Looking for a safe alternative? Search Amazon Canada for JAMP Venlafaxine XR 37.5 →

Hazard / Issue

Labelling

Issued by

Communications and Public Affairs Branch

⚠️ What You Should Do

Check the capsules in your pharmacy bottle of JAMP Venlafaxine XR 37.5 mg capsules to make sure it contains 37.5 mg capsules (grey / pink in colour) and not 150 mg capsules (caramel in colour). If you are unsure, contact your pharmacist to check if your bottle contains the correct capsules.If you see incorrect capsules, stop taking the medication and contact your pharmacy immediately for a replacement product. Return the affected product to your pharmacy for proper disposal.Contact your health care professional if you have taken the wrong dose of your medication. Seek medical attention immediately if you experience any serious side effects from Venlafaxine XR, which may include allergic reactions, gastrointestinal bleeding, seizures, heart rhythm problems, blurred vision, eye pain, or severe headache.Contact JAMP Pharma Corporation by email at alewicki@jamppharma.com if you have questions about this recall.Report any health product-related side effects or complaints to Health Canada.
View official government recall